Multicell Techs Stock Analysis

Multicell Techs is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Multicell Techs pink sheet analysis is to determine its intrinsic value, which is an estimate of what Multicell Techs is worth, separate from its market price. There are two main types of Multicell Techs' stock analysis: fundamental analysis and technical analysis.
The Multicell Techs pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Multicell Techs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

Multicell Pink Sheet Analysis Notes

The company had not issued any dividends in recent years. Multicell Techs had 1:5 split on the 20th of May 2005. MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island. Multicell Techs operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.The quote for Multicell Techs is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Multicell Techs contact Gerald Newmin at 401-762-0045 or learn more at www.multicelltech.com.

Multicell Techs Investment Alerts

Multicell Techs generated a negative expected return over the last 90 days
Multicell Techs has some characteristics of a very speculative penny stock
Multicell Techs currently holds 36.43 K in liabilities. Multicell Techs has a current ratio of 0.19, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Multicell Techs until it has trouble settling it off, either with new capital or with free cash flow. So, Multicell Techs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Multicell Techs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Multicell to invest in growth at high rates of return. When we think about Multicell Techs' use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 49.32 K. Net Loss for the year was (380.07 K) with profit before overhead, payroll, taxes, and interest of 49.32 K.
Multicell Techs currently holds about 281.12 K in cash with (1.09 M) of positive cash flow from operations.

Multicell Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 1 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Multicell Techs's market, we take the total number of its shares issued and multiply it by Multicell Techs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Multicell Profitablity

The company has Profit Margin (PM) of (0.31) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.6) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.6.

Technical Drivers

In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Multicell Techs, as well as the relationship between them.

Multicell Techs Price Movement Analysis

Execute Study
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Multicell Techs middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Multicell Techs. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Multicell Techs Outstanding Bonds

Multicell Techs issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Multicell Techs uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Multicell bonds can be classified according to their maturity, which is the date when Multicell Techs has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

About Multicell Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Multicell Techs prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Multicell shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Multicell Techs. By using and applying Multicell Pink Sheet analysis, traders can create a robust methodology for identifying Multicell entry and exit points for their positions.
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island. Multicell Techs operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Multicell Techs to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Optimization Now

   

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
All  Next Launch Module

Additional Tools for Multicell Pink Sheet Analysis

When running Multicell Techs' price analysis, check to measure Multicell Techs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Multicell Techs is operating at the current time. Most of Multicell Techs' value examination focuses on studying past and present price action to predict the probability of Multicell Techs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Multicell Techs' price. Additionally, you may evaluate how the addition of Multicell Techs to your portfolios can decrease your overall portfolio volatility.